Skip to content

Epstein-Barr Virus (EBV) Antibody Profile: IgM and IgG to Viral Capsid Antigen (VCA) and Early Antigen (EA) in Lymphocytes

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies in your blood that your immune system produces in response to Epstein-Barr virus (EBV), a common virus that can cause infections like mononucleosis.

Quick summary

["Helps diagnose or monitor EBV infection by detecting immune system activity against the virus in lymphocytes (white blood cells)."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
103739-9
Short code
EBV lymph multi Bld/T
Synonyms
EBV lymph multi Bld/T
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms like fever, fatigue, swollen lymph nodes, or sore throat that could suggest an EBV infection. It may also be used to confirm a diagnosis after initial suspicion or to track how your body responds to treatment over time.

What to Expect Before the Test

No special preparation is needed. You may have a blood draw from a vein in your arm, similar to other blood tests. The process is quick and usually painless. If you’re on blood-thinning medication, let your provider know beforehand.

What the Test Results Mean

The test looks for specific antibodies (IgM and IgG) produced by your immune system in response to EBV. IgM antibodies appear early in infection and fade over time, while IgG antibodies develop later and persist longer. Elevated levels of these antibodies can indicate past or current EBV exposure.

Common Reasons for Testing

This test is often used to diagnose EBV-related illnesses like infectious mononucleosis, assess immune responses in immunocompromised patients, or evaluate chronic conditions linked to EBV, such as certain cancers or long-term fatigue.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

EBV Antibody Screening (Lymphocyte-Based)

Frequently asked questions

What does an elevated IgM antibody mean?
An elevated IgM antibody suggests an active EBV infection, as IgM is typically produced early in the immune response to the virus. This can help confirm a recent infection, such as mononucleosis, but results should be interpreted alongside other clinical findings.
Can this test detect latent EBV infection?
This test primarily detects active immune responses to EBV, not latent infection. For latent EBV detection, other tests (like PCR for viral DNA) or different antibody profiles may be used, depending on clinical needs.
Is this test sensitive for all EBV-related conditions?
No, this test is most useful for diagnosing acute or recent EBV infections. It may not detect all EBV-related conditions, such as certain cancers or chronic infections, which may require additional testing.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy